Conferences and Events

^{Emil J Freireich Hematology Grand Rounds}

The MD Anderson Cancer Center Emil J Freireich Hematology Grand Rounds now has a virtual format. This series will highlight the incredible research taking place at MD Anderson Cancer Center while showcasing leaders from our research community, in an effort to remain engaged and inspired during the COVID-19 pandemic. Hosted by the Leukemia department in collaboration with the Lymphoma/Myeloma department, and Stem Cell Transplantation and Cellular Therapy department, we aim to strengthen the connections between the scientific and medical community at MD Anderson Cancer Center, our colleagues, patients and friends from around the world.

After attending this activity, the target audience of physicians from Leukemia, Lymphoma/Myeloma, Stem Cell Transplantation and Research Staff, Nurses, Data Coordinators, Laboratory Staff, Post-Doctoral Fellows, Instructors, and Research Staff in Lab should be able to:

Assess clinical and translational research in lymphoma and plasma cell dyscrasia (knowledge);
Increase collaboration between disciplines regarding lymphoma and plasma cell dyscrasia (knowledge, competence, performance);
Update knowledge and collaboration in trials and research (knowledge, competence, performance);
Accelerate the speed of translational research and clinical trials to achieve better patient outcomes (knowledge, competence, performance, patient outcomes);

The series will occur every Wednesday at 8 a.m. CST and will consist of a 45-minute presentation followed by a Q&A session.

Event Details

Time: 8 - 9 a.m. CST

Recurrence: Wednesdays

Virtual Platform: Zoom
Email HGR Coordinator for Meeting Details

Audience: Internal & external colleagues from around the world

Organized by: The Leukemia Department under the direction of Farhad Ravandi, MD. For more information, contact fravandi@mdanderson.org.

Special thanks to Shannon Bailey, Dr. Ravandi's faculty support, for coordinating the virtual weekly seminars.

Previous Recordings

"Myeloproliferative Neoplasms (MPN): From ASH 2019 to EHA 2020"

Watch recording (includes captioning)

Srdan Verstovsek, M.D., Ph.D.
“Assessment of minimal residual/measurable acute myeloid leukemia by multi-parameter flow cytometry”

Watch recording (includes captioning)

Sa Wang, M.D.
“Updates from the world of FLT3”

Watch recording (includes captioning)

Mark Levis, M.D., Ph.D.
“Management of Acute Myeloid Leukemia in 2020”

Watch recording (includes captioning)

Farhad Ravandi, M.D.
“Turning on an Apoptotic Switch in Leukemia: BCL-2 and Beyond”

Watch recording (includes captioning)

Marina Y. Konopleva, M.D., Ph.D.
“Management of Philadelphia chromosome positive acute lymphoblastic leukemia-The Italian perspective”

Watch recording (includes captioning)

Giovanni Martinelli, M.D.
“Overcoming adaptive therapy resistance in leukemia”

Watch recording (includes captioning)

Daniel Starczynowski, Ph.D.
“Fractionated Busulfan Conditioning Regimen: Progress?”

Watch recording (includes captioning)

Uday Popat, M.D.
“Hematopoietic stem cells in normal, stressed and malignant hematopoiesis”

Watch recording (includes captioning)

Simona Colla, Ph.D.
"Best of ALL 2021"

Watch recording (includes captioning)

Elias Jabbour, M.D.
“CLL ASH 2020 Update”

Watch recording (includes captioning)

William Wierda, M.D., Ph.D.
"Update on Myeloproliferative Neoplasms from ASH 2020"

Watch recording (includes captioning)

Srdan Verstovsek, M.D., Ph.D.
“Treatment of MDS in 2021: an ASH update”

Watch recording (includes captioning)

Guillermo Garcia-Manero, M.D.
“Where do we go with FLT3 inhibitors from here”

Watch recording (includes captioning)

Keith Pratz, M.D.
"Recently approved drugs in the frontline treatment of AML | Can biology refine indications?"

Watch recording (includes captioning)

Stéphane de Botton M.D., Ph.D.
"Progress in Leukemia 2021"

Watch recording (includes captioning)

Hagop M. Kantarjian, M.D.
"AMLSG: Clinical and translational research projects“

Watch recording (includes captioning)

Prof. Dr. Konstanze Döhner
"Evolution of Epigenetic Therapies in MDS & AML”

Watch recording (includes captioning)

Hagop M. Kantarjian, M.D.
“AML from an Australian Perspective”

Watch recording (includes captioning)

Andrew Wei, M.D.
"An Update on IDH1/2- mutant AML"

Watch recording (includes captioning)

Courtney D. DiNardo, M.D., MSCE
“Erythrocytosis: Perspective of the Hematologist”

Watch recording (includes captioning)

Cristhiam M Rojas Hernandez, M.D.
“Chimeric Antigen Receptor T-cell Therapy for Hematologic Malignancies”

Watch recording (includes captioning)

Jim Kochenderfer, M.D.
"Biology and novel therapy of AML with 3q26.2 lesions and EVI1 overexpression”

Watch recording (includes captioning)

Kapil N. Bhalla, M.D., F.A.C.P.
"Hairy Cell Leukemia and the BRAF-V600E Mutation: A Journey Through Genetics, Biology, Diagnosis, and Therapy"

Watch recording (includes captioning)

Enrico Tiacci, M.D.
"Mechanisms of Bone Marrow Failure in Human Acute Myeloid Leukemia & Therapeutic Interventions"

Watch recording (includes captioning)

Tian Yi Zhang, M.D., Ph.D.
“Primers on eosinophilic hematologic neoplasms”

Watch recording (includes captioning)

Andreas Reiter, M.D.
“Improving outcomes in patients allografted for Acute Myeloid Leukemia”

Watch recording (includes captioning)

Prof. Charles Craddock CBE, FRCP (UK), FRCPath, DPhil, FMedSci
"Core Binding Factor AML Making Good Better”

Watch recording (includes captioning)

Gautam Borthakur, M.D.
“Updates post ASCO-EHA (and some SOHO)”

Watch recording (includes captioning)

Hagop Kantarjian, M.D.
'CLL: the role of T cells, and update on ibrutinib in high risk CLL'

Watch recording (includes captioning)

Jan A. Burger, M.D., Ph.D.
“Cytogenetics And NGS In Routine Diagnostic Workup In Hematology As Supported By AI”

Watch recording (includes captioning)

Prof. Dr. med. Dr. phil. Torsten Haferlach
'Understanding CLL biology through mouse models of human genetics'

Watch recording (includes captioning)

Elisa Ten Hacken, Ph.D.